1ISG-024 Biosimilars switch: do doctors and patients revert back after switching?

Background

Biosimilars are a great opportunity to improve the efficiency of health systems. Their quality is certified by regulatory agencies and high-quality clinical trials. However, some reluctance about switching between originals and biosimilars still remains between doctors and patients because of different reasons. Purpose To determine if doctors or patients revert back to initial treatment after switching between biologic...